TrialActa neuropathologica2025

Immunohistochemical evaluation of a trial of gantenerumab or solanezumab in dominantly inherited Alzheimer disease.

Charles D Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.